CapsoVision (CV) Net Income (2024 - 2025)

CapsoVision's (CV) quarterly Net Income came in at -$7.4 million in Q4 2025, down 59.39% year-on-year from -$18.2 million in Q4 2024, and up 6.65% quarter-over-quarter from -$7.9 million in Q3 2025.

CapsoVision (CV) Net Income (2024 - 2025) Analysis & Trends

CapsoVision has disclosed Net Income across 2 years of filings, most recently posting -$7.4 million for Q4 2025.

  • Net Income for Q4 2025 came in at -$7.4 million, down 59.39% year-over-year; the trailing twelve-month figure through Dec 2025 was -$24.6 million (changed N/A YoY), and the FY2025 annual result was -$25.3 million, down 27.22% from the prior year.
  • Net Income came in at -$7.4 million for Q4 2025 at CapsoVision, up from -$7.9 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$4.6 million in Q2 2025 to a low of -$7.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.08 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 745.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 411.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 CapsoVision 161.82 Mn 151.71 Mn 1.95 Mn -7.39 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.39 Mn
Sep 30, 2025 -7.92 Mn
Jun 30, 2025 -4.63 Mn
Dec 31, 2024 -4.64 Mn
Sep 30, 2024 -5.79 Mn
Jun 30, 2024 -5.27 Mn